Radicle Science has launched Radicle Discovery Gen 2

Radicle Science (San Diego, CA) has announced the launch of the latest version of its proof-as-a-service platform, Radicle Discovery Gen 2, which combines rigorous clinical trials, AI, data, and crowdsourcing to validate the effects of natural products across diverse populations. Tech-enabled, and deeply customizable, Discovery Gen 2 accelerates speed-to-claim, increases the likelihood of success, and unlocks deeper insights.

The upgraded Discovery Gen 2 includes:

• Expanded health indications supporting dozens of the top health categories and customization options that include outcomes, eligibility, duration, and statistical plan.
• Flexible trial designs that allow for a variety of scientific and marketing goals. Clients can design double-blind, randomized, placebo-controlled clinical trials for the development of strong claims, or open-label trials to test variations on packages, usage instructions, flavors, or product forms. Brands now also have the option to leverage in-home use tests for sensory and impression reports.
• Brands will now be able to test for nearly 100 blood, saliva, stool, and vaginal biomarkers with clinically validated direct-to-consumer testing kits.
• A menu of digital measurements from wearables and other connected devices such as Bluetooth-connected scales, smart-phone based cognition tests, AI-analyzed facial scans, and integrations with Apple Watch, Oura Ring, and FitBit.
• The inclusion of Radicle’s proprietary Precision Insights analytics at no additional cost. Precision Insights is made possible by large, diverse trial data combined with advanced biostatistics and AI cluster analysis, and provides actionable intelligence on the differences in product benefits, usage behavior, consumer perceptions, and side effects among subpopulations.

“Radicle Discovery Gen 2 isn’t just an upgrade—it’s a complete reimagination of clinical research, starting with the end in mind,” said Dr. Jeff Chen and Pelin Thorogood, co-founders of Radicle Science. “We’ve engineered an intelligent platform that combines cutting-edge AI, validated biomarkers, and exponentially flexible trial designs to deliver the kind of speed, precision, and depth the wellness industry has never seen. This is more than innovation, it’s a revolution in how natural products are clinically validated and precision targeted to subpopulations. Our clients demanded more. Gen 2 delivers exponentially more—without the exponential cost.”

Additionally, Radicle is augmenting research teams with AI agents to streamline the management of large-scale trials. These agents can assist with participant communication and engagement to enhance responsiveness, scalability, and consistency, handling time-intensive coordination tasks to free up Radicle’s human scientists to focus on higher-order activity, improving the overall trial experience without sacrificing the human touch. Radicle is also able to use AI to learn from its aggregate anonymized clinical dataset.

Recently, Radicle introduced a health tracker, called Journey, that would allow brands to collect real-world evidence from consumers. Watch our interview with the Radicle Science co-founders to learn more about Journey.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}